 VALSARFEC D
|
Fecofar
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.x 30 | $31.555,33 | (30/04/26) |
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $12.155,39 |
|
|
|
|
| 160/25 mg comp.x 30 | $36.656,42 | (30/04/26) |
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $12.401,10 |
|
|
|
|
| 80/12.5 mg comp.x 30 | $27.182,95 | (30/04/26) |
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $9.423,95 |
|
|
|
|
| 80/12.5 mg comp.x 28 | $25.245,79 | (29/04/26) |
|
|
|
| 160/12.5 mg comp.x 28 | $29.306,56 | (29/04/26) |
| PAMI |
|
| AF $14.541,40 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $13.539,35 |
|
|
|
|
| 160/25mg comp.x 28 | $34.044,14 | (29/04/26) |
| PAMI |
|
| AF $17.022,07 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $18.276,93 |
|
|
|
|
| |
